Recognition, Pathogenesis, and Treatment of Different Stages of Nephropathy in Patients With Type 2 Diabetes Mellitus

作者: George L. Bakris

DOI: 10.4065/MCP.2010.0713

关键词: SurgeryDiabetic nephropathyKidney diseaseDiabetes mellitusType 2 Diabetes MellitusAlbuminuriaMedicineNephropathyRisk factorInternal medicineType 2 diabetesGeneral Medicine

摘要: Nephropathy is a common microvascular complication among patients with type 2 diabetes mellitus and major cause of kidney failure. It characterized by albuminuria (≥300 mg/d) reduced glomerular filtration rate often present at the time diagnosis after has been exposed to chronic hyperglycemia during prediabetic phase. A low ( ) also an independent risk factor for cardiovascular events death. Detection diabetic nephropathy its initial stages provides opportunity early therapeutic interventions prevent or delay onset complications improve outcomes. An intensive multifactorial management approach needed that targets all determinants simultaneously. The strategy should comprise lifestyle modifications (smoking cessation, weight loss, increased physical activity, dietary changes) coupled achievement blood glucose, pressure, lipid goals are evidence-based. Prescribing decisions take into account demographic factors, level impairment, adverse effects, hypoglycemia, tolerability, effects on other factors comorbidities. Regular comprehensive follow-up assessments appropriate adjustment regimen maintain control vital component care, including referral specialists, when required.

参考文章(123)
UK Prospective Diabetes Study Group, None, Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 BMJ. ,vol. 317, pp. 703- 713 ,(1998)
Effects of intensive glucose lowering in type 2 diabetes The New England Journal of Medicine. ,vol. 358, pp. 2545- 2559 ,(2008) , 10.1056/NEJMOA0802743
James Shepherd, John JP Kastelein, Vera Bittner, Prakash Deedwania, Andrei Breazna, Stephen Dobson, Daniel J Wilson, Andrea Zuckerman, Nanette K Wenger, TNT (Treating to New Targets) Investigators, None, Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: the TNT (Treating to New Targets) study. Journal of the American College of Cardiology. ,vol. 51, pp. 1448- 1454 ,(2008) , 10.1016/J.JACC.2007.11.072
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. The New England Journal of Medicine. ,vol. 358, pp. 2560- 2572 ,(2008) , 10.1056/NEJMOA0802987
Monisankar Roy, Noman Mahmood, Clive Rosendorff, Evidence for Aggressive Blood Pressure–Lowering Goals in Patients with Coronary Artery Disease Current Atherosclerosis Reports. ,vol. 12, pp. 134- 139 ,(2010) , 10.1007/S11883-010-0094-7
Brian Radbill, Barbara Murphy, Derek LeRoith, Rationale and Strategies for Early Detection and Management of Diabetic Kidney Disease Mayo Clinic proceedings. ,vol. 83, pp. 1373- 1381 ,(2008) , 10.4065/83.12.1373
Holly J Kramer, Quan Dong Nguyen, Gary Curhan, Chi-yuan Hsu, Renal Insufficiency in the Absence of Albuminuria and Retinopathy Among Adults With Type 2 Diabetes Mellitus JAMA. ,vol. 289, pp. 3273- 3277 ,(2003) , 10.1001/JAMA.289.24.3273
Temduang Chuahirun, Cathy Hudson, Timothy Seipel, Apurv Khanna, Jan Simoni, Ronald B. Harrist, Donald E. Wesson, Cigarette smoking exacerbates and its cessation ameliorates renal injury in type 2 diabetes. The American Journal of the Medical Sciences. ,vol. 327, pp. 57- 67 ,(2004) , 10.1097/00000441-200402000-00001